Juno Diagnostics is a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions.
Juno Diagnostics has raised $200K in total funding. The most recent round was Undisclosed. The last funding was announced in March 2023.
Juno Diagnostics's investors include Perceptive Advisors, Colle Capital Partners, Zoic Capital, Bioverge, Milad Alucozai.
Juno Diagnostics is headquartered in San Diego, United States.
Juno Diagnostics is a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions.
Juno Diagnostics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Juno Diagnostics — Funding & Investors." VCBacked, March 10, 2023, https://www.vcbacked.co/company/juno-diagnostics. Accessed August 14, 2026.
VCBacked. (2023). Juno Diagnostics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/juno-diagnostics
{{cite web |title=Juno Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/juno-diagnostics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated